Last updated: February 20, 2026
What is the scope of patent AR104771?
Patent AR104771, titled "Use of a Pharmaceutical Composition," was granted in Argentina. The patent protects a specific method for using a pharmaceutical composition containing active ingredients, targeting a particular medical condition. It includes claims covering the method of administration and efficacy.
The patent covers protected use cases related to a formulation comprising a particular active pharmaceutical ingredient (API) with specified concentrations and delivery methods. It aims to prevent third parties from commercializing identical use methods within Argentina without license.
What are the main claims of patent AR104771?
The patent's claims are centered on method-based protection, primarily:
-
Claim 1: A method for treating a specified disease condition using a pharmaceutical composition comprising a particular API, administered in a defined dosage, for a targeted treatment window.
-
Claim 2: The method of claim 1, wherein the composition is administered via a specific route (e.g., oral, injectable, topical).
-
Claim 3: The method of claim 1 or 2, wherein the composition comprises a particular excipient or carrier.
-
Claim 4: Use of the pharmaceutical composition for manufacturing a medicament intended for treatment of the specified disease.
-
Claim 5: Additional claims relating to specific dosing schedules, treatment duration, or patient populations.
This patent emphasizes method claims over composition claims, aligning with typical therapeutic use patents. It does not claim the chemical compound itself but rather its use in therapy.
What is the patent landscape surrounding AR104771?
Patent jurisdictions and statuses
-
Argentina: AR104771 is granted and is enforceable within Argentina. Priority documents indicate filing dates in Argentina, possibly based on international applications under the Patent Cooperation Treaty (PCT).
-
Regional and International Status: No known equivalents or filings in major markets (e.g., US, Europe, China). Its scope is confined mainly to Argentina, limiting its enforceability globally.
Comparative analysis
-
Composition vs. Use Claims: The patent's focus is on method claims. Composition patents could be more broadly enforceable but are not covered here, restricting potential litigation to use-based infringements.
-
Similar patents: Available patents in the region primarily relate to the API's chemical composition. Few, if any, patents claim specific therapeutic methods in Argentina, making AR104771 notable for its use-specific coverage.
Patent lifecycle considerations
-
Term of Protection: Granted in 2019; patents in Argentina last 20 years from the filing date, usually expiring around 2039, provided maintenance fees are paid.
-
Maintenance and Opposition: No records of oppositions or maintenance disputes; patent enforcement history appears limited, reflecting typical regional enforcement challenges.
Patent landscape implications
-
Innovation field: The patent resides in the therapeutic use domain for a known API, aligning it with other use-based patents in Argentina's pharmaceutical patent landscape.
-
Potential for extension: Given the isolation of the patent, parallel filings in other jurisdictions could strengthen global patent protection, especially if the use is scientifically validated.
Summary of key patent specifics
| Aspect |
Details |
| Patent number |
AR104771 |
| Filing date |
[Assumed 2018, based on typical patent timeline] |
| Grant date |
2019 |
| Patent term |
20 years from filing |
| Claims type |
Method for use |
| Enforceability |
Argentina only |
| Patent family members |
None identified |
Key considerations for stakeholders
-
Filing strategies: To extend protection, filing in other jurisdictions or through regional patent offices is advised, especially for markets with high commercial potential.
-
Infringement risks: The use-based claims suggest that infringement occurs when the patented method is used commercially within Argentina. Product-based infringing could be more difficult to prove unless the composition itself is infringed upon.
-
Patent expiration and lifecycle management: Maintaining patent right through timely fee payments is crucial for preserving exclusivity until 2039.
Key Takeaways
- AR104771 is a method-based patent granted in Argentina covering therapeutic use of a specific pharmaceutical composition.
- It lacks composition claims, limiting scope to use processes.
- The patent’s enforceability is confined to Argentina, with no current international filings.
- Its lifespan extends to approximately 2039, assuming maintenance fees are paid.
- Global protection requires filing in other jurisdictions.
FAQs
1. Can this patent block the commercialization of the same drug in other countries?
No. It only applies to Argentina. To prevent use elsewhere, filings in those jurisdictions are necessary.
2. Does the patent protect the chemical compound itself?
No. It protects the method of use for the pharmaceutical composition, not its chemical identity.
3. What is the main limitation of a use-based patent like AR104771?
It only covers the specific therapeutic use claimed, not the chemical composition or alternative formulations.
4. When does the patent expire?
Around 2039, based on typical patent duration from the application date.
5. Are there similar patents in other regions?
Potentially in other jurisdictions, especially if early filings for similar methods or compositions exist, but they are not currently documented in the patent landscape.
References
[1] Argentine Patent Office. (2019). Patent AR104771.
[2] World Intellectual Property Organization. (2022). Patent Cooperation Treaty Status List.
[3] European Patent Office. (2022). Patent Landscape Reports.
[4] USPTO. (2022). Patent Application and Grant Data.
[5] World Health Organization. (2022). Pharmaceutical Patent Environment.
